Skip to content
Clinical Trials – home

Region Nordjylland

Research site

Denmark Moelleparkvej 10, 9000 Aalborg, Denmark

  • 5 trials recruiting
  • Alcohol use disorder · Bipolar I disorder · Cardiac failure acute
  • Adult patients

About Specializations

Region Nordjylland in Aalborg, Denmark specialises in clinical trials of conditions such as Alcohol use disorder, Bipolar I disorder, Cardiac failure acute, Colitis ulcerative, and other specialisations. This site conducts important research.

Main research areas of the site

Gastroenterology

The medical center is at the forefront of gastroenterology research, focusing on innovative treatments for ulcerative colitis. The center's work in this area aims to improve the quality of life for patients with moderately to severely active ulcerative colitis through advanced therapeutic approaches.

  • Ulcerative Colitis
  • Clinical Remission Induction
  • Therapeutic Innovations

By exploring new treatment modalities, the center contributes significantly to the understanding and management of chronic inflammatory bowel diseases.

Nephrology

Specializing in nephrology, the center conducts pioneering research on idiopathic membranous nephropathy and severe proteinuria. The focus is on enhancing patient outcomes through the evaluation of novel therapeutic agents and their safety profiles.

  • Idiopathic Membranous Nephropathy
  • Severe Proteinuria
  • Pharmacokinetics and Efficacy

The center's research efforts are instrumental in developing safer and more effective treatments for kidney-related disorders.

Oncology

In the field of oncology, the center is renowned for its research on rectal cancer. By comparing neoadjuvant chemotherapy with standard treatment protocols, the center aims to optimize therapeutic strategies for locally advanced rectal cancer.

  • Rectal Cancer
  • Neoadjuvant Chemotherapy
  • Standard Treatment Protocols

This research is pivotal in enhancing both short-term and long-term outcomes for cancer patients.

Infectious Diseases

The center's expertise in infectious diseases is exemplified by its research on blood poisoning in patients undergoing hemodialysis. The focus is on the efficacy of prophylactic antibiotic treatments to prevent severe infections.

  • Blood Poisoning
  • Hemodialysis
  • Antibiotic Prophylaxis

Through this research, the center aims to reduce infection rates and improve patient safety during renal replacement therapy.

Head and Neck Oncology

In the specialized area of head and neck oncology, the center is advancing the treatment of squamous cell carcinoma through hypoxia-profile guided therapies. This research seeks to enhance treatment responses by tailoring interventions based on genetic profiles.

  • Squamous Cell Carcinoma
  • Hypoxia-Profile Guided Therapy
  • Radiotherapy/Chemoradiotherapy

The center's work in this domain is crucial for developing personalized treatment plans that improve patient outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Moelleparkvej 109000 AalborgDenmark
Recruiting now
5 trials
Conditions studied
14

More sites in AalborgDenmark

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

11 clinical trials

A study to compare continuous infusion and intermittent injections of furosemide and amiloride hydrochloride in patients hospitalized with acute heart failure and fluid overload

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Furosemide
  • Sponsor:Region Midtjylland

Bipolar I disorder+1

Recruiting

A study testing xanomeline tartrate and trospium chloride added to current treatment for adults with bipolar I disorder experiencing mania

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Schizophrenia+1

Recruiting

Study on the Effects of Tirzepatide on Reducing Alcohol Intake in Patients with Schizophrenia and Alcohol Use Disorder

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Region Hovedstaden

Renal failure

Recruiting

Study on Preventing Blood Infections in Hemodialysis Patients Using Amoxicillin/Clavulanic Acid or Clindamycin

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin
  • Sponsor:Region Sjaelland

Study on the Safety and Effects of AP1189 for Patients with Idiopathic Membranous Nephropathy and Severe Proteinuria

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Resomelagon
  • Sponsor:Synact Pharma ApS

Pulmonary embolism

Not yet recruiting

Enoxaparin or drug combination versus no anticoagulant treatment for incidental subsegmental pulmonary embolism in cancer patients

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Region Hovedstaden

Study on Improving Bowel Function in Patients with Low Anterior Resection Syndrome Using Glycerol Suppositories or Transanal Irrigation

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Glycerol
  • Sponsor:Region Midtjylland

Study of Nimorazole Treatment Based on Hypoxia Profile in Head and Neck Cancer Patients Receiving Radiotherapy with Cisplatin

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Region Midtjylland

Major depression

Not recruiting

Study on the Effects of Psilocybin (COMP360) for Adults with Treatment-Resistant Depression

InvestigationalNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Psilocybine
  • Sponsor:Compass Pathfinder Limited

Rectal cancer

Not recruiting

Study Comparing Neoadjuvant Chemotherapy with Capecitabine and Oxaliplatin to Standard Treatment for Patients with Locally Advanced Rectal Cancer

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Region Sjaelland

Colitis ulcerative

Not recruiting

Study of RO7790121 Compared to Placebo for Treatment of Adults with Moderate to Severe Ulcerative Colitis

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:RO7790121
  • Sponsor:F. Hoffmann-La Roche AG
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.